Browse drugs

…ally, we observed VISTA upregulation on myeloid cells following Aza treatment.Conclusions Immune evasion and exhaustion are recogni…

….56SFR 46 (59.7%)13 (68.4%)p= 0.59Mann Whitney U 6-TGN pre/post Allopurinol (mean)222.3- 396.2p = 0.00296-MMPN level pre/post allopurinol (…

…e need for metabolite monitoring and vigilance when prescribing AZA in SLE pregnancies.…

…owledging historically high prescribing of EFZ, we believe that Efavirenz is a previously unknown cause of DI-ALH. Awareness is important…

… (OR 0.225; CI 0.051 to 0.990; p 0.048) and hydroxychloroquine (HCQ) (OR 0.293; CI 0.115 to 0.746; p 0.01) was associated with a lo…

…tational age was 37.7 weeks (SD 4.7). During pregnancy 68% used hydroxychloroquine (HCQ) in monotherapy, 23% used a combination of HCQ and azathio…

…11), antimalarials (n= 55), tacrolimus (n= 27), everolimus (1), belimumab (BLM) (19) and anifrolumab (1). After a follow-up of 59.7±46 mo…

…ase inhibition (DNMTi) using azacytidine (AZA), zebularine, and GSK3685032, added during GMP-compatible manufacturing of B7-H3 -targeting …

… ≥2, and inadequate response/intolerance (IR) to TNFa blockers, vedolizumab, ustekinumab, JAK inhibitors, or S1P receptor modulators (BIO/J…